179 related articles for article (PubMed ID: 24651162)
1. No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases.
Xu B; Liu P
PLoS One; 2014; 9(3):e92585. PubMed ID: 24651162
[TBL] [Abstract][Full Text] [Related]
2. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A
Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience.
Lin HN; Liu CY; Hong YC; Pai JT; Yang CF; Yu YB; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Tzeng CH; Chen PM
Leuk Lymphoma; 2010 Dec; 51(12):2208-14. PubMed ID: 21054150
[TBL] [Abstract][Full Text] [Related]
4. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.
Tokunaga T; Shimada K; Yamamoto K; Chihara D; Ichihashi T; Oshima R; Tanimoto M; Iwasaki T; Isoda A; Sakai A; Kobayashi H; Kitamura K; Matsue K; Taniwaki M; Tamashima S; Saburi Y; Masunari T; Naoe T; Nakamura S; Kinoshita T
Blood; 2012 Mar; 119(12):2837-43. PubMed ID: 22308294
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma.
Huang C; Zhang H; Gao Y; Diao L; Liu L
Technol Cancer Res Treat; 2020; 19():1533033820964231. PubMed ID: 33073702
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.
Crickx E; Poullot E; Moulis G; Goulabchand R; Fieschi C; Galicier L; Meignin V; Coppo P; Delarue R; Casasnovas O; Roos-Weil D; de Leval L; Parrens M; Michel M; Dupuis J; Le Bras F; Fataccioli V; Martin-Garcia N; Godeau B; Haïoun C; Gaulard P; Mahévas M
Eur J Haematol; 2019 Jul; 103(1):35-42. PubMed ID: 30985955
[TBL] [Abstract][Full Text] [Related]
8. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
[TBL] [Abstract][Full Text] [Related]
9. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Survival Outcome, and Prognostic Nomogram of Patients with Angioimmunoblastic T-cell Lymphoma: a Population-based Analysis.
Chen HZ; Tao YX; Zhou Y; Zhong QF; Zhou LQ; Shi YK
Curr Med Sci; 2022 Dec; 42(6):1220-1230. PubMed ID: 36547871
[TBL] [Abstract][Full Text] [Related]
11. Involvement of spleen is associated with shorter survival in patients with angioimmunoblastic T cell lymphoma.
Huang Y; Zeng R; Xue C; Huang Q; Yu D; Shao L; Zhou H; Wu H
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9721-9726. PubMed ID: 37244875
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.
Li Y; Yang C; Mao L; Wang J; Li C; Qian W
Medicine (Baltimore); 2017 Sep; 96(39):e8091. PubMed ID: 28953629
[TBL] [Abstract][Full Text] [Related]
13. Advances in understanding of angioimmunoblastic T-cell lymphoma.
Chiba S; Sakata-Yanagimoto M
Leukemia; 2020 Oct; 34(10):2592-2606. PubMed ID: 32704161
[TBL] [Abstract][Full Text] [Related]
14. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
[TBL] [Abstract][Full Text] [Related]
15. Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
Ren Y; Gu Y; Wang W; Wang J; Li X; Wang Y; Gao H; Dong X; Tian Y
Cell Cycle; 2016 Jun; 15(12):1545-51. PubMed ID: 27124741
[TBL] [Abstract][Full Text] [Related]
16. Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma.
Yang YQ; Liang JH; Wu JZ; Wang L; Qu XY; Cao L; Zhao XL; Huang DP; Fan L; Li JY; Xu W
Leuk Res; 2016 Mar; 42():88-92. PubMed ID: 26764222
[TBL] [Abstract][Full Text] [Related]
17. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
[TBL] [Abstract][Full Text] [Related]
18. Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan.
Kao HW; Lin TL; Shih LY; Dunn P; Kuo MC; Hung YS; Wu JH; Tang TC; Chang H; Kuo TT; Ou CW; Wang PN
Int J Hematol; 2016 Aug; 104(2):256-65. PubMed ID: 27095042
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
20. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta-analysis of 56 cases.
Tan LH; Tan SY; Tang T; Lim ST; Tan D; Lim LC; Kam GL; Loh TP; Tao M; Koay ES
Histopathology; 2012 Mar; 60(4):570-85. PubMed ID: 22251198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
